Message Bookmarked
Bookmark Removed
Apparently I can mix and match. The mRNA vaccines did great in that NIH study as a booster to J&J, increasing antibodies like crazy. Moderna did best, but the study was done with a full dose, and the Moderna booster is only a half dose. Pfizer did did well too. Second shot of J&J didn't do so great. But they just looked at antibody count, and snapped the picture after 2 weeks, where the mRNA vaccines would be expected to excel. J&J is a slower climb up, but also a slower descent. Plus the study wasn't meant to evaluate which makes the best booster. Next month they promise T-cell results from the same study, which would help round out the picture.
Poll Results
| Option | Votes |
| Moderna booster (half dose) | 8 |
| Second shot of J&J | 2 |
| Pfizer booster (full dose) | 2 |
| Wait for the T-cell info | 0 |
― Thus Sang Freud, Friday, 22 October 2021 21:13 (four years ago)
You must be logged in to post. Please either login here, or if you are not registered, you may register here.